Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
Aclaris Therapeutics, a clinical-stage biopharmaceutical company focused on immuno-inflammatory diseases, announced its participation in the 2026 Jefferies Global Healthcare Conference where its CEO and leadership will present via a fireside chat and webcast. The event aims to communicate the company's progress and future plans to investors.